Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer

Completed · Phase 1/Phase 2

Conditions studied: Head and Neck Cancer, Radiation Toxicity

In brief

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III oropharyngeal cancer.

Key facts

Study ID
NCT00006360
Run by
Radiation Therapy Oncology Group
Starts
2001-02-01
Expected to finish
2016-12-01
Last updated by the study team
2020-10-22

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.